PRAME and neoplasm: Interestingly, PRAME tumour expression was shown to suppress the expression and secretion of multiple proinflammatory cytokines and mediators of T-cell activation, differentiation and cytolysis during inflammation [185], further highlighting the role of PRAME in regulating immune activation in the tumour microenvironment (TME).